CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,285,604
- in 7 filings, $33.3M under 10b5-1 plans
Net −$33,285,604. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | BAKER BROS. ADVISORS LP Director | Grant or award | +2,505 | 33,445,860 | ||
| 2023-06-14 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +11,294 | 11,294 | ||
| 2023-06-14 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +11,294 | 11,294 | ||
| 2023-06-14 | HARRIGAN EDMUND Director | Grant or award | +2,505 | 11,500 | ||
| 2023-06-14 | HARRIGAN EDMUND Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,294 | 11,294 | ||
| 2023-06-14 | High Katherine A Director | Grant or award | +2,505 | 7,993 | ||
| 2023-06-14 | High Katherine A Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,294 | 11,294 | ||
| 2023-06-14 | FOUSE JACQUALYN A Director | Grant or award | +2,505 | 13,978 | ||
| 2023-06-14 | FOUSE JACQUALYN A Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,294 | 11,294 | ||
| 2023-06-14 | Schaffert Susanne Director | Grant or award | +2,505 | 4,130 | ||
| 2023-06-14 | Schaffert Susanne Director | Shares withheld for taxes | −488 | $61.44 | $30K | 3,642 |
| 2023-06-14 | Schaffert Susanne Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,294 | 11,294 | ||
| 2023-06-14 | Clancy Paul J Director | Grant or award | +2,505 | 14,211 | ||
| 2023-06-14 | Clancy Paul J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,294 | 11,294 | ||
| 2023-06-14 | BIENAIME JEAN JACQUES Director | Grant or award | +2,505 | 15,493 | ||
| 2023-06-14 | BIENAIME JEAN JACQUES Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,294 | 11,294 | ||
| 2023-06-14 | BRAWLEY OTIS W Director | Grant or award | +2,505 | 5,904 | ||
| 2023-06-14 | BRAWLEY OTIS W Director | Grant or award · Non-Qualified Stock Option (right to buy) | +11,294 | 11,294 | ||
| 2023-06-05 | CAGNONI PABLO J President, R&D | Grant or award | +192,400 | 192,400 | ||
| 2023-06-05 | CAGNONI PABLO J President, R&D | Grant or award | +179,613 | 179,613 |
Page 34 of 35 · 681 trades